Ken Newcomer, MD

Specialty: Surgical Oncology
Locations

Cancers Treated:

Adrenal Anal Breast Carcinoid Colon Colorectal Esophageal Gallbladder & Bile Duct Liver Melanoma Neuroendocrine Tumors Pancreatic Sarcoma Skin Thyroid Parathyroid

Research Interests:

  • Targeted therapeutics for cancer
  • Precision oncology
  • Cancer surgery outcomes

Biography

I grew up in the Washington DC area. I attended Brown University where I played football and majored in Chemistry with honors. I graduated from Washington University in Saint Louis School of Medicine in 2018 and completed residency in general surgery at Washington University School of Medicine / Barnes Jewish Hospital in 2025.

Positions

Roswell Park Comprehensive Cancer Center

  • Surgical Oncology Fellow
  • Department of Surgical Oncology

Background

Education and Training

  • 2018 - MD - Washington University, St. Louis, MI

Residency

  • 2018-2025 - General Surgery, Washington University, St. Louis / Barnes Jewish Hospital

Professional Memberships

  • Alpha Omega Alpha
  • American College of Surgeons
  • Americas Hepato-Pancreato-Biliary Association
  • Society of Surgical Oncology

Publications

  • Trametinib thwarts activation of survival pathways induced by pro-ferroptotic drug conjugate ACXT-3102 resulting in enhanced pancreatic cancer cell death
  • Surgical Cancer Patients’ Attitudes and Beliefs about Cannabis at a Midwest Comprehensive Cancer Center
  • Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress
  • Neoadjuvant chemotherapy is associated with increased risk of postoperative DVT after distal pancreatectomy for pancreatic adenocarcinoma: a NSQIP analysis
  • Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies